CORPORATE PROFILE
Listed on the Main Board of the Singapore Exchange in October 2005, C & O
Pharmaceutical Technology (Holdings) Limited (“C&O”) is an established and
integrated pharmaceutical group in China. Our business model spans the entire value
chain in the pharmaceutical industry, from research and development, to
manufacturing, as well as marketing and distribution of C&O branded and third party
pharmaceutical products via an extensive distribution network covering all parts of
China.
Our product portfolio comprises C&O branded products, imported products (to which
we hold exclusive distribution rights) and third party products. Most of our own
products are included in the National Health Insurance Scheme, focusing primarily on
anti-infection and gastrointestinal drugs, drugs for ageing adults, as well as other
specialised drugs.
With a strong emphasis on research and development, we continually expand the
range of our C&O branded products with a deep pipeline of generic and patented
drugs. At the same time, we relentlessly source for new pharmaceutical and healthcare
products to be carried under our extensive distribution network in China.
With an integrated business model, we offer one-stop solutions to other
pharmaceutical companies both in China and outside of China with our Contract
Research (“CRO”) and Contract Manufacturing (“CMO”) services, as well as product
registration and distribution services.
Page Updated as at 12/03/08